Skip to content

メインメニューに戻る

企業情報
研究開発
患者さん・一般の皆さま
医療関係者の皆さま
- 製品関連情報
- MSDマニュアルプロフェッショナル版
報道関係者の皆さま
働きがいのある職場
採用情報

MSDストーリーズ

詳細はこちら

お問い合わせ

世界各国の拠点（英語） See our worldwide locations and country contact information

どのようなコンテンツをお探しですか？

Search for:

健康と薬の情報
>
MSDくすりとワクチンの情報一覧
>
シルガード®9を接種される方とその保護者の方へ

シルガード®9を接種される方とその保護者の方へ

これから接種される方はこちら

シルガード®9を接種される方へ

すでに接種された方はこちら

シルガード®9を接種された方へ

Connect with us on social

MSDについて

・会社概要
・MSDストーリーズ
・企業としての責任

患者さん・一般の皆さま

・健康と薬の情報
・MSDマニュアル家庭版
・採用情報

医療関係者の皆さま

・製品関連情報
・MSDマニュアルプロフェッショナル版
・研究者主導研究（IIS）支援
・MSDにおける医学教育助成

個人情報の取り扱い
ご利用条件
COPYRIGHT
サイトマップ
アクセシビリティ
MSD社員向け災害対策情報

Copyright © 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.

Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA

This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept